Cargando…
175. Clindamycin versus linezolid for Group A Streptococcal bloodstream infections?: A comparative effectiveness study of adjunctive antitoxin therapy at 137 US Hospitals
BACKGROUND: Adjunctive clindamycin has survival benefit in invasive Group A streptococcus (GAS) infections. Like clindamycin, linezolid also leads to decreased toxin and virulence factor production. However, rising clindamycin resistance among GAS isolates and inadequate clinical data on linezolid b...
Autores principales: | Babiker, Ahmed, Warner, Sarah, Li, Xioabai, Walker, Morgan, Lawandi, Alexander, Kadri, Sameer S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677800/ http://dx.doi.org/10.1093/ofid/ofad500.248 |
Ejemplares similares
-
473. Impact of Adjunctive Clindamycin in Invasive β-Hemolytic Streptococcal Infections: A Propensity Score-matched Analysis of 1956 β-lactam Treated Patients from 118 US Hospitals
por: Babiker, Ahmed, et al.
Publicado: (2019) -
1370. Role of Clindamycin Versus Linezolid for Serious Group A Streptococcal Infections
por: Heil, Emily, et al.
Publicado: (2021) -
272. Do Empiric Antibiotics Improve Outcomes in Clinically Stable Patients Admitted with COVID-19 Pneumonia? Retrospective Cohort Study of 221 U.S. Hospitals, March 1st, 2020-December 31st, 2020
por: Lawandi, Alexander, et al.
Publicado: (2022) -
Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole
por: Dilley, Michelle, et al.
Publicado: (2021) -
Streptococcal Septicæmia: A Case Successfully Treated with Streptococcal (Scarlatinal) Antitoxin
por: Fleming, John
Publicado: (1934)